Structure Therapeutics surges on promising early stage obesity drug data

Shares of Structure Therapeutics soared 60% on Friday after the drug developer’s oral obesity treatment succeeded in a small early-stage study.

The once-daily drug helped participants reduce up to 4.5 kgs of body weight on average after four weeks of treatment, the company said.